Logo image of KLXE

KLX ENERGY SERVICES HOLDING (KLXE) Stock Fundamental Analysis

NASDAQ:KLXE - Nasdaq - US48253L2051 - Common Stock - Currency: USD

4.4  -0.03 (-0.68%)

Fundamental Rating

1

Taking everything into account, KLXE scores 1 out of 10 in our fundamental rating. KLXE was compared to 59 industry peers in the Energy Equipment & Services industry. KLXE has a bad profitability rating. Also its financial health evaluation is rather negative. KLXE has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

KLXE had negative earnings in the past year.
KLXE had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: KLXE reported negative net income in multiple years.
KLXE had a positive operating cash flow in 4 of the past 5 years.
KLXE Yearly Net Income VS EBIT VS OCF VS FCFKLXE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 -200M -400M -600M

1.2 Ratios

KLXE's Return On Assets of -9.78% is on the low side compared to the rest of the industry. KLXE is outperformed by 86.21% of its industry peers.
With a Return On Equity value of -1904.00%, KLXE is not doing good in the industry: 96.55% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -9.78%
ROE -1904%
ROIC N/A
ROA(3y)-29.57%
ROA(5y)-20.4%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
KLXE Yearly ROA, ROE, ROICKLXE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 -200 -400 -600 -800 -1K

1.3 Margins

With a Gross Margin value of 22.17%, KLXE perfoms like the industry average, outperforming 41.38% of the companies in the same industry.
In the last couple of years the Gross Margin of KLXE has grown nicely.
The Profit Margin and Operating Margin are not available for KLXE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 22.17%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y21.34%
GM growth 5Y8.54%
KLXE Yearly Profit, Operating, Gross MarginsKLXE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 -100 -200

More info and screens

1

2. Health

2.1 Basic Checks

KLXE does not have a ROIC to compare to the WACC, probably because it is not profitable.
KLXE has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, KLXE has more shares outstanding
The debt/assets ratio for KLXE has been reduced compared to a year ago.
KLXE Yearly Shares OutstandingKLXE Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M
KLXE Yearly Total Debt VS Total AssetsKLXE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

2.2 Solvency

KLXE has an Altman-Z score of 0.10. This is a bad value and indicates that KLXE is not financially healthy and even has some risk of bankruptcy.
KLXE's Altman-Z score of 0.10 is on the low side compared to the rest of the industry. KLXE is outperformed by 82.76% of its industry peers.
KLXE has a debt to FCF ratio of 78.64. This is a negative value and a sign of low solvency as KLXE would need 78.64 years to pay back of all of its debts.
KLXE has a worse Debt to FCF ratio (78.64) than 63.79% of its industry peers.
A Debt/Equity ratio of 105.76 is on the high side and indicates that KLXE has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 105.76, KLXE is doing worse than 96.55% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 105.76
Debt/FCF 78.64
Altman-Z 0.1
ROIC/WACCN/A
WACC10.48%
KLXE Yearly LT Debt VS Equity VS FCFKLXE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 100M 200M 300M

2.3 Liquidity

KLXE has a Current Ratio of 1.24. This is a normal value and indicates that KLXE is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.24, KLXE is not doing good in the industry: 87.93% of the companies in the same industry are doing better.
A Quick Ratio of 1.08 indicates that KLXE should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.08, KLXE is not doing good in the industry: 75.86% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.24
Quick Ratio 1.08
KLXE Yearly Current Assets VS Current LiabilitesKLXE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M

More info and screens

2

3. Growth

3.1 Past

KLXE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -212.55%.
The Revenue for KLXE has decreased by -19.56% in the past year. This is quite bad
KLXE shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 22.62% yearly.
EPS 1Y (TTM)-212.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-208.51%
Revenue 1Y (TTM)-19.56%
Revenue growth 3Y17.76%
Revenue growth 5Y22.62%
Sales Q2Q%-14.37%

3.2 Future

The Earnings Per Share is expected to decrease by -39.30% on average over the next years. This is quite bad
The Revenue is expected to decrease by -4.78% on average over the next years.
EPS Next Y-414.91%
EPS Next 2Y-85.36%
EPS Next 3Y-39.3%
EPS Next 5YN/A
Revenue Next Year-21.43%
Revenue Next 2Y-9.27%
Revenue Next 3Y-4.78%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
KLXE Yearly Revenue VS EstimatesKLXE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M
KLXE Yearly EPS VS EstimatesKLXE Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 10 -10 -20 -30

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

KLXE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for KLXE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
KLXE Price Earnings VS Forward Price EarningsKLXE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, KLXE is valued cheaper than 82.76% of the companies in the same industry.
KLXE's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 17.6
EV/EBITDA 4.02
KLXE Per share dataKLXE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

A cheap valuation may be justified as KLXE's earnings are expected to decrease with -39.30% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-85.36%
EPS Next 3Y-39.3%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for KLXE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

KLX ENERGY SERVICES HOLDING

NASDAQ:KLXE (2/24/2025, 3:15:07 PM)

4.4

-0.03 (-0.68%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)10-31 2024-10-31/amc
Earnings (Next)03-06 2025-03-06/amc
Inst Owners33.3%
Inst Owner Change-96.41%
Ins Owners5.69%
Ins Owner Change6.36%
Market Cap73.92M
Analysts85.71
Price Target8.67 (97.05%)
Short Float %10.67%
Short Ratio9.32
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)15.75%
Min EPS beat(2)-8.7%
Max EPS beat(2)40.2%
EPS beat(4)1
Avg EPS beat(4)-2178.56%
Min EPS beat(4)-8625.15%
Max EPS beat(4)40.2%
EPS beat(8)1
Avg EPS beat(8)-1099%
EPS beat(12)2
Avg EPS beat(12)-779.06%
EPS beat(16)3
Avg EPS beat(16)-651.49%
Revenue beat(2)1
Avg Revenue beat(2)-0.65%
Min Revenue beat(2)-3.51%
Max Revenue beat(2)2.21%
Revenue beat(4)1
Avg Revenue beat(4)-4.42%
Min Revenue beat(4)-10.6%
Max Revenue beat(4)2.21%
Revenue beat(8)2
Avg Revenue beat(8)-3.36%
Revenue beat(12)4
Avg Revenue beat(12)1.36%
Revenue beat(16)8
Avg Revenue beat(16)7.05%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)6.98%
EPS NQ rev (3m)6.98%
EPS NY rev (1m)-12.37%
EPS NY rev (3m)-12.37%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.1
P/FCF 17.6
P/OCF 1.11
P/B 29.57
P/tB 73.92
EV/EBITDA 4.02
EPS(TTM)-2.96
EYN/A
EPS(NY)-1.48
Fwd EYN/A
FCF(TTM)0.25
FCFY5.68%
OCF(TTM)3.98
OCFY90.37%
SpS43.93
BVpS0.15
TBVpS0.06
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.78%
ROE -1904%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 22.17%
FCFM 0.57%
ROA(3y)-29.57%
ROA(5y)-20.4%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y21.34%
GM growth 5Y8.54%
F-Score3
Asset Turnover1.52
Health
Industry RankSector Rank
Debt/Equity 105.76
Debt/FCF 78.64
Debt/EBITDA 3.3
Cap/Depr 70.58%
Cap/Sales 8.48%
Interest Coverage N/A
Cash Conversion 83.29%
Profit Quality N/A
Current Ratio 1.24
Quick Ratio 1.08
Altman-Z 0.1
F-Score3
WACC10.48%
ROIC/WACCN/A
Cap/Depr(3y)53.63%
Cap/Depr(5y)94.75%
Cap/Sales(3y)5.13%
Cap/Sales(5y)9.07%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-212.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-208.51%
EPS Next Y-414.91%
EPS Next 2Y-85.36%
EPS Next 3Y-39.3%
EPS Next 5YN/A
Revenue 1Y (TTM)-19.56%
Revenue growth 3Y17.76%
Revenue growth 5Y22.62%
Sales Q2Q%-14.37%
Revenue Next Year-21.43%
Revenue Next 2Y-9.27%
Revenue Next 3Y-4.78%
Revenue Next 5YN/A
EBIT growth 1Y-111.3%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year28.42%
EBIT Next 3Y18.73%
EBIT Next 5YN/A
FCF growth 1Y111.02%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y885.88%
OCF growth 3Y25.77%
OCF growth 5YN/A